Metabolomic Technologies Inc Medical Equipment Deals and Alliances Profile...
SummaryMetabolomic Technologies Inc MTI is a biotechnology company that develops metabolomicbased diagnostic systems. The company's products comprise ColoDx PolypDx BreastDx ProstateDx CeliacDx...
View ArticleEnterome Brings in a 32M Series D for its MicrobiomeBased Therapies
Enterome will use the money to progress two of its leading microbiome programs for the treatment of Crohns disease and an aggressive form of brain cancer. Enterome is a pioneer in the exciting field of...
View ArticleSeres Therapeutics Reports SER287 Phase 1b Microbiome Analyses that Provide...
Microbiome analyses demonstrate engraftment of SER287derived bacteria; microbiome compositional changes correlate with clinical remission SER287 engraftment maintained four weeks after completion of...
View ArticleSetpoint Medical Inc Medical Equipment Deals and Alliances Profile Report...
SummarySetPoint Medical Inc. SetPoint Medical is a biotechnology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company employs a scientific...
View ArticleTakeda announces its intention to acquire TiGenix
PRESS RELEASEREGULATED INFORMATIONInside Information Communication in accordance with section 8 Â1 of the Belgian Royal Decree of 27 April 2007 on public takeover bids Takeda announces its intention to...
View ArticleTakeda agrees $630m takeover of TiGenix
Takeda already had a strong working relationship with TiGenix after previously signing a licensing agreement with the Belgiumbased pharma company on a treatment for Crohns disease. It has now moved to...
View ArticleTakeda Starts the Year Bidding for a Belgian Stem Cell Therapy Biotech
Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead stem cell therapy for Crohn&8217;s disease Cx601. Short of two years after partnering with TiGenix for...
View ArticleTopiVert Pharma Limited Positive results from TOP1288 Phase 1 study
LONDON UNITED KINGDOM Marketwired 010818 TopiVert Pharma Ltd TopiVert announces positive results from the Phase 1 study with its oral formulation of TOP1288 for the treatment of ulcerative colitis...
View ArticleCelgene Corporation Announces Preliminary 2017 Unaudited Results and 2018...
Preliminary Q4 2017 total revenue of $3.5 billion a 17 percent increase YY Preliminary FY 2017 total revenue of $13.0 billion a 16 percent increase YY Reaffirming 2020 total revenue and adjusted...
View ArticleStem Cell Injection for Perianal Fistulae in Crohn Disease Is Effective for a...
Phase III trial results show efficacy of this investigational therapy up to 52 weeks.
View ArticleScientists identify immune cells that keep gut fungi under control
Weill Cornell Medicine Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi according to a new study from Weill Cornell Medicine...
View ArticleMount Sinai research discovers possible link between Crohn's & Parkinson's in...
The Mount Sinai Hospital Mount Sinai School of Medicine Findings could lead to new treatments and early diagnosis.
View ArticleFungi and Intestinal Inflammation Finding May Open Door to New IBD Therapies
Weill Cornell Medicine researchers have found that immune&160;cells that process food and bacterial antigens in the intestines control the intestinal population of fungi. Defects in the...
View Article20152023 World Budesonide Market Research Report by Product Type EndUser...
SummaryBudesonide BUD sold under the brand name Pulmicort among others is a steroid medication. It is available as an inhaler pill and nasal spray.The inhaled form is used in the long term management...
View ArticlePossible link between Crohn's and Parkinson's in Jewish population
Researchers have just discovered that patients in the Ashkenazi Jewish population with Crohn's disease a chronic inflammatory of the digestive system are more likely to carry the LRRK2 gene mutation....
View ArticleImmune cells that keep gut fungi under control
Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi according to a new study from Weill Cornell Medicine scientists. Defects in the...
View ArticleSandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
Novartis International AG Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA. Processed and transmitted by Nasdaq Corporate Solutions.The issuer is solely responsible for...
View ArticleResearchers Discover Possible Link between Crohns & Parkinsons Disease in...
NewsMount Sinai Researchers have just discovered that patients in the Ashkenazi Jewish population with Crohns disease a chronic inflammatory of the digestive system are more likely to carry the LRRK2...
View ArticleTiGenix Transparency notifications pursuant to Article 14 of the Law of May 2...
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2 2007 Leuven Belgium January 16 2018 2200h CET TiGenix NV Euronext Brussels and Nasdaq TIG;...
View ArticleScientists shed light on a key molecular mechanism of autoimmune and...
An international team of researchers has unraveled a crucial aspect of the molecular basis of autoimmune and inflammatory diseases such as psoriasis rheumatoid arthritis and Crohn's disease. Focusing...
View Article